Your browser doesn't support javascript.
loading
Fatores relacionados à flebite em idosos com infusão intravenosa de amiodarona / Factors associated with phlebitis in elderly patients with amiodarone intravenous infusion
Buzatto, Leandro Loureiro; Massa, Gabriella Pinna; Peterlini, Maria Angelica Sorgini; Whitaker, Iveth Yamaguchi.
  • Buzatto, Leandro Loureiro; Hospital Israelita Albert Einstein. São Paulo. BR
  • Massa, Gabriella Pinna; Hospital Israelita Albert Einstein. São Paulo. BR
  • Peterlini, Maria Angelica Sorgini; Hospital Israelita Albert Einstein. São Paulo. BR
  • Whitaker, Iveth Yamaguchi; Hospital Israelita Albert Einstein. São Paulo. BR
Acta paul. enferm ; 29(3): 260-266, May-jun. 2016. tab
Article in Portuguese | LILACS, BDENF | ID: lil-796001
RESUMO
Resumo Objetivo Identificar fatores associados à ocorrência de flebite decorrente da infusão intravenosa periférica de amiodarona em idosos. Métodos Coorte prospectiva, observacional sobre fatores de risco para ocorrência de flebite em pacientes com idade acima de 60 anos que receberam infusão intravenosa periférica de amiodarona, internados, no ano de 2012, nas unidades Coronarianas (22 leitos) e Semi Intensivas Gerais (43 leitos) de um hospital privado de grande porte, localizado na cidade de São Paulo, Brasil. Resultados Do total de 102 idosos, 34 (33,3%) apresentaram flebite. A flebite foi mais frequente em mulheres (43,6%), em membro dominante puncionado (36,2%), em veias basílica ou cefálica do antebraço (41,2%), nos dispositivos de calibre 20G (40,0%), em curativo estéril IV Fix® (39,3%), em cateter Intima® (34,3%) e quando houve reposicionamento do dispositivo (33,3%); mas essas variáveis não se associaram estatisticamente à flebite. Ausência de flebite na infusão rápida exclusiva foi marginalmente significante (p= 0,051) comparada aos diferentes tipos de infusão. Conclusão Um terço dos idosos estudados apresentou flebite, verificou-se ausência de flebite somente nas infusões rápidas exclusivas.
ABSTRACT
Abstract Objective To verify the incidence of phlebitis and identify factors associated with the development of phlebitis due to peripheral intravenous infusion of amiodarone in elderly patients. Methods Prospective and observational cohort study on risk factors for the development of phlebitis in patients aged over 60 years, who received peripheral intravenous infusion of amiodarone, hospitalized in 2012 in the coronary care (22 beds) and general semi-intensive units (43 beds) of a large private hospital in São Paulo, Brazil. Results Of the total 102 elderly people, 34 (33.3%) had phlebitis. It was more frequent in women (43.6%), in the dominant punctured member (36.2%), in the forearm basilica or cephalic veins (41.2%), in caliber 20G devices (40.0%), in IV Fix® sterile dressings (39.3%), in Intima® catheters (34.3%) and when there was device repositioning (33.3%). However, these variables were not statistically associated with phlebitis. Phlebitis absence in the exclusive bolus infusion was marginally significant (p = 0.051) compared to different types of infusion. Conclusion One-third of the studied elderly patients presented phlebitis. There was absence of phlebitis only in exclusive bolus infusions.


Full text: Available Index: LILACS (Americas) Type of study: Observational study / Prognostic study / Risk factors Language: Portuguese Journal: Acta paul. enferm Journal subject: Nursing Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Israelita Albert Einstein/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Observational study / Prognostic study / Risk factors Language: Portuguese Journal: Acta paul. enferm Journal subject: Nursing Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Israelita Albert Einstein/BR